首页> 外文期刊>世界急诊医学杂志(英文) >Expression patterns of plasma von Willebrand factor and serum interleukin-8 in patients with early-stage severe pulmonary contusion
【24h】

Expression patterns of plasma von Willebrand factor and serum interleukin-8 in patients with early-stage severe pulmonary contusion

机译:早期严重肺挫伤患者血浆血管性假血友病因子和血清白细胞介素8的表达模式

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: von Willebrand factor (vWF) is only released from endothelial cells and platelets and is an in vivo and in vitro marker of endothelial injury in septic patients with acute lung injury (ALI). Interleukin-8 (IL-8), as a proinflammatory mediator causing recruitment of inflammatory cells, induces an increase in oxidant stress mediators and makes it as a key parameter for localized inflammation. However, it has not been well established whether the level of serum IL-8 is associated with the severity of lung injury and whether it is a prognosis marker for severe lung contusion. This study was to investigate the expression of plasma vWF and IL-8 and their association with the severity and outcomes of severe pulmonary contusion. METHODS: A total of 63 patients were divided into a severe pulmonary contusion with acute respiratory distress syndrome (ARDS) group and a non-ARDS group, or a survivor group and a non-survivor group, or an injury severity score (ISS) <20 group and an ISS ≥20 group. Another 20 healthy volunteers served as controls. The levels of plasma vWF and serum IL-8 were measured by enzyme-linked immunosorbent assay (ELISA) at 1, 3, 5 and 7 days after injury. The expression patterns of the plasma vWF and serum IL-8 were compared between different groups. RESULTS: The concentrations of plasma vWF and serum IL-8 were significantly increased in all severe pulmonary contusion patients at all time points in comparison with the control group. The concentrations of plasma vWF in patients with ARDS increased during the whole study period, but vWF in patients with non-ARDS increased gradually until day 5 and then decreased at day 7. The concentration of serum IL-8 showed a similar expression pattern in both groups, but the expression increased more significantly in the ARDS group than in the non-ARDS group. Interestingly, both plasma vWF and serum IL-8 levels steadily increased in the non-survivor group. Furthermore, the level of plasma vWF was higher in the ISS≥20 group than in the ISS<20 group. The level of serum IL-8 in the ISS≥20 group was consistently high, while that in the ISS<20 group peaked at day 3 and decreased at day 5. In addition, the level of plasma vWF was positively correlated with platelet count, but negatively correlated with oxygen index. The level of serum IL-8 was positively correlated with white blood cell count and ISS score, and inversely correlated with oxygen index. CONCLUSION: The elevated levels of plasma vWF and serum IL-8 in severe pulmonary contusion patients reflect the severity of pulmonary injury and patients outcomes, suggesting that the plasma vWF and serum IL-8 are sensitive markers for clinical evaluation of the severity of pulmonary injury and predication of patient prognosis.
机译:背景:von Willebrand因子(vWF)仅从内皮细胞和血小板释放,并且是败血症急性肺损伤(ALI)患者内皮损伤的体内和体外标志物。白介素8(IL-8),作为引起炎症细胞募集的促炎介质,诱导了氧化应激介质的增加,使其成为局部炎症的关键参数。但是,尚不清楚血清IL-8的水平是否与肺损伤的严重程度有关,以及它是否是严重肺挫伤的预后指标。本研究旨在探讨血浆vWF和IL-8的表达及其与严重肺挫伤的严重程度和预后的关系。方法:将63例患者分为急性呼吸窘迫综合征(ARDS)组和非ARDS组,或幸存者组和非幸存者组或损伤严重程度评分(ISS)< 20组和ISS≥20组。另外20名健康志愿者作为对照。在损伤后1、3、5和7天通过酶联免疫吸附测定(ELISA)测量血浆vWF和血清IL-8的水平。比较不同组之间血浆vWF和血清IL-8的表达模式。结果:与对照组相比,所有严重肺挫伤患者在所有时间点血浆vWF和血清IL-8的浓度均显着升高。在整个研究期间,ARDS患者的血浆vWF浓度均升高,但非ARDS患者的vWF浓度逐渐升高直至第5天,然后在第7天降低。两种血清IL-8的表达模式相似各组,但ARDS组的表达比非ARDS组更显着。有趣的是,在非幸存者组中血浆vWF和血清IL-8水平稳定增加。此外,ISS≥20组的血浆vWF水平高于ISS <20组。 ISS≥20组的血清IL-8水平始终很高,而ISS <20组的血清IL-8水平在第3天达到峰值,而在第5天下降。此外,血浆vWF水平与血小板计数呈正相关,但与氧指数呈负相关。血清IL-8水平与白细胞计数和ISS评分呈正相关,与氧指数呈负相关。结论:重度肺挫伤患者血浆vWF和血清IL-8水平升高反映了肺损伤的严重程度和患者预后,提示血浆vWF和血清IL-8是临床评估肺损伤严重程度的敏感指标和患者预后的预测。

著录项

  • 来源
    《世界急诊医学杂志(英文)》 |2011年第002期|122-126|共5页
  • 作者单位

    ICU, the First Affiliated Hospital of Soochow University, Soochow 215006, China;

    ICU, the First Affiliated Hospital of Soochow University, Soochow 215006, China;

    Blood Institute, Soochow University, Soochow, China;

    Wujiang Affiliated Hospital, Nantong University, Wujiang 215200, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号